These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1792330)

  • 1. Quality assurance in conservative treatment of early breast cancer. Report on a consensus meeting of the EORTC Radiotherapy and Breast Cancer Cooperative Groups and the EUSOMA (European Society of Mastology).
    Bartelink H; Garavaglia G; Johansson KA; Mijnheer BJ; Van den Bogaert W; van Tienhoven G; Yarnold J
    Radiother Oncol; 1991 Dec; 22(4):323-6. PubMed ID: 1792330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality assurance of the EORTC Trial 22881/10882: boost versus no boost in breast conserving therapy. An overview.
    van Tienhoven G; Mijnheer BJ; Bartelink H; González DG
    Strahlenther Onkol; 1997 Apr; 173(4):201-7. PubMed ID: 9111608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assurance of the EORTC trial 22881/10882: "assessment of the role of the booster dose in breast conserving therapy": the Dummy Run. EORTC Radiotherapy Cooperative Group.
    van Tienhoven G; van Bree NA; Mijnheer BJ; Bartelink H
    Radiother Oncol; 1991 Dec; 22(4):290-8. PubMed ID: 1792323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality control in breast cancer treatment: what information can the surgeon provide?
    Fentiman IS
    Radiother Oncol; 1991 Dec; 22(4):226-9. PubMed ID: 1792311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.
    Whelan TJ; Lada BM; Laukkanen E; Perera FE; Shelley WE; Levine MN
    Cancer Prev Control; 1997 Aug; 1(3):228-40. PubMed ID: 9765748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I--III breast cancer(1).
    Poortmans PM; Venselaar JL; Struikmans H; Hurkmans CW; Davis JB; Huyskens D; van Tienhoven G; Vlaun V; Lagendijk JJ; Mijnheer BJ; De Winter KA; Van der Hulst MH; Van den Bogaert WF
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1399-408. PubMed ID: 11286848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary lymph node dose with tangential breast irradiation.
    Reed DR; Lindsley SK; Mann GN; Austin-Seymour M; Korssjoen T; Anderson BO; Moe R
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):358-64. PubMed ID: 15667953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiotherapy in the conservative management of breast cancer].
    Yamashita T; Nakazawa M; Soukawa M; Hayashi S; Sunagawa Y; Sekiguchi K
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):763-8. PubMed ID: 1605651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different radiation techniques to deliver therapeutic dose to the axilla in patients with sentinel lymph node-positive breast cancer: Doses, techniques challenges and clinical considerations.
    Wang S; Kirova YM; Shan SC; Cai G; Ou D; Cao L; Cai R; Chen JY
    Cancer Radiother; 2018 Dec; 22(8):767-772. PubMed ID: 30523794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
    Bartelink H; Maingon P; Poortmans P; Weltens C; Fourquet A; Jager J; Schinagl D; Oei B; Rodenhuis C; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan D; Dubois JB; Remouchamps V; Mirimanoff RO; Collette S; Collette L;
    Lancet Oncol; 2015 Jan; 16(1):47-56. PubMed ID: 25500422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of the method used at Créteil for early breast cancer: 1970-1990.
    Marinello G; Calitchi E; Le Bourgeois JP; Pierquin B
    Radiother Oncol; 1991 Dec; 22(4):266-8. PubMed ID: 1792319
    [No Abstract]   [Full Text] [Related]  

  • 12. The Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer: Perspectives for Pathologists.
    Schnitt SJ; Moran MS; Houssami N; Morrow M
    Arch Pathol Lab Med; 2015 May; 139(5):575-7. PubMed ID: 25153620
    [No Abstract]   [Full Text] [Related]  

  • 13. [Conservative surgery and radiotherapy of early breast cancer].
    Okawa T; Haga S; Kajiwara T; Kimura T; Hamano K; Ito Y; Izo M
    Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):1206-9. PubMed ID: 1470146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of UK breast radiotherapy techniques: background prior to the introduction of the quality assurance programme for the START (standardisation of radiotherapy) trial in breast cancer.
    Winfield E; Deighton A; Venables K; Hoskin PJ; Aird EG
    Clin Oncol (R Coll Radiol); 2002 Aug; 14(4):267-71. PubMed ID: 12206636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost - GEC-ESTRO Breast Cancer Working Group practical recommendations.
    Strnad V; Major T; Polgar C; Lotter M; Guinot JL; Gutierrez-Miguelez C; Galalae R; Van Limbergen E; Guix B; Niehoff P; Lössl K; Hannoun-Levi JM
    Radiother Oncol; 2018 Sep; 128(3):411-420. PubMed ID: 29691075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial.
    Poortmans PM; Collette L; Horiot JC; Van den Bogaert WF; Fourquet A; Kuten A; Noordijk EM; Hoogenraad W; Mirimanoff RO; Pierart M; Van Limbergen E; Bartelink H;
    Radiother Oncol; 2009 Jan; 90(1):80-5. PubMed ID: 18707785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entrance and exit TL-dosimetry in the conservative treatment of breast cancer: a pilot study for the EORTC-Radiotherapy Cooperative Group.
    Hamers HP; Johansson KA; Venselaar JL; de Brouwer P; Hansson U; Moudi C
    Radiother Oncol; 1991 Dec; 22(4):280-4. PubMed ID: 1792321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Brachytherapy of the tumor bed after breast conserving surgery: new radiotherapeutic option in the management of early breast cancer].
    Polgár C; Major T; Somogyi A; Fodor J; Sulyok Z; Tóth J; Forrai G; Németh G
    Orv Hetil; 1999 Jun; 140(26):1461-6. PubMed ID: 10442002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative treatment of breast cancer in Europe: report of the Groupe Européen de Curiethérapie.
    Pierquin B; Mazeron JJ; Glaubiger D
    Radiother Oncol; 1986 Jul; 6(3):187-98. PubMed ID: 3749523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keynote Address at the American Society of Breast Surgeons 18th Annual Meeting : Current and Future Application of Intraoperative Radiotherapy (IORT) in the Curative and Palliative Treatment of Breast Cancer.
    Wenz F
    Ann Surg Oncol; 2017 Oct; 24(10):2811-2817. PubMed ID: 28766200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.